Optimising response to immunotherapies in pleural mesothelioma: clinical data and alternative models for the evaluation of new strategies
Along with ongoing trials testing innovative immunotherapies and strategies in pleural mesothelioma, original pre-clinical models are required to optimize these strategies and discover new ones for our patients.
Authors
- Christophe Blanquart (ORCID: https://orcid.org/0000-0002-0917-3747)
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR)
- Onco Lille (FR)
Publication Details
- Journal
- Thorax
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1136/thorax-2025-223284
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00